Stanislas Conseiller: Every Second, the Coagulation Cascade Protects Us
Stanislas Conseiller, Philanthropy and Fundraising Development Officer at the Paris-Saclay School of Medicine, shared a post on LinkedIn:
”Every second, in our body, a choreography of incredible precision is played: the coagulation cascade.
It protects us from bleeding… But sometimes this balance is out of whack.
In France, bleeding disorders directly affect about 1% of the population. And coagulation problems are the cause of 150,000 thromboses and pulmonary embolisms each year.
They cause heart attacks and strokes, the 3rd leading cause of death in France with about 40,000 deaths per year and the 1st cause of acquired disability in adults.
The interactions between inflammation, hemostasis and thrombosis are complex — and still too little known.
This is precisely what Professor Cécile DENIS and his team are trying to understand within the H.I.Th. (Haemostasis, Inflammation and Thrombosis) project of Paris-Saclay School of Medicine and INSERM (Unit 1176).
Their objective: to deepen the knowledge of the mechanisms of the coagulation cascade in order to decipher the pathophysiology of bleeding diseases — such as von Willebrand disease or hemophilia — and to improve the diagnosis and treatment of bleeding disorders.
Thanks to its recognized expertise, the H.I.Th. unit has established itself as an international leader, combining translational research, major clinical applications and therapeutic innovation.
Its unique nanobody platform plays a key role in the development of innovative diagnostic tools and the conduct of preclinical trials.
Supporting and publicizing this work means contributing to better prevention and more targeted treatments.
Because, in every drop of blood, there is a mechanism essential to life.”
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 3, 2025, 08:23The 1st Participant in A New CHECK-NIRS Clinical Study is Enrolled!
-
Nov 3, 2025, 08:15Bert van Meurs Shares the New Late-breaking Results from the iMODERN Trial
-
Nov 3, 2025, 07:10Lisa Shea Shares Key Takeaways from NORD Summit 2025
-
Nov 3, 2025, 06:49Darshan Doshi on Results of iMODERN and ILIAS ANOCA Studies Presented at TCT 2025
-
Nov 2, 2025, 14:172019 ESC/EAS Guidelines for the Management of Dyslipidaemias Discussion with Lale Tokgözoğlu and Jeanine Roeters van Lennep
-
Nov 3, 2025, 09:13Claudio Carrubba on How Timing Truly Matters in Trauma Embolization
-
Nov 3, 2025, 08:46Rachel Lamerton and Colleagues on Activation of Platelets in Flow Cytometry
-
Nov 3, 2025, 04:56Nirupama Ramadas and Erica Sparkenbaugh on Thromboinflammation in SCD
-
Nov 2, 2025, 14:21Claude Franceschi: I Advise You to Understand the Hemodynamic Pathophysiology of Venous Diseases Rather than Blindly Applying Ablation Techniques or Venous Stent Placement
-
Nov 2, 2025, 14:15Krishna Aragam: Why are (DCM) and Heart Failure About Twice as Common in Individuals of Self-Identified Black Race?
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
-
Nov 3, 2025, 09:24Stephen Cornelissen: It’s Not Just About Emergencies — It’s About Everyday Care, Chronic Conditions and Hope
-
Nov 3, 2025, 06:57Maria Elisa Mancuso Reflects on 2025 Annual Congress of the Italian Association of Hemophilia Centres
-
Nov 3, 2025, 05:46Chandra Viswanathan: When Blood Safety Fails, We All Bleed - A Call for Reform and Responsibility
-
Nov 2, 2025, 14:17Anamaria B: Your Mother Still Runs Part of Your DNA
-
Nov 2, 2025, 10:57Paul Bolaji on Launching The First Centralised Nigerian National Stroke Registry